Paxman
48.35 SEK
-1.33 %
Less than 1K followers
PAX
First North Stockholm
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
-1.33 %
+3.98 %
+5.80 %
-13.97 %
-26.96 %
-36.04 %
+46.52 %
-17.49 %
+343.58 %
Paxman is active in scalp cooling, which is used for patients undergoing chemotherapy. The company's product Paxman Scalp Cooler is used to minimize hair loss in patients during treatment. The Scalp Cooler is a freestanding, mobile and electrically powered cooling unit that cools the patient's scalp via a cooling cap. Paxman was founded in 1996 and is headquartered in Karlshamn.
Read moreMarket cap
1.13B SEK
Turnover
495.1K SEK
Revenue
313.35M
EBIT %
1.36 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
21/5
2026
Interim report Q1'26
22/5
2026
General meeting '26
21/8
2026
Interim report Q2'26
All
Press releases
ShowingAll content types
Paxman publicerar bolagets årsredovisning för 2025
Paxman publishes the company’s annual report for 2025
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools